The type III secretion effector NleE inhibits NF-kappaB activation.


The complex host-pathogen interplay involves the recognition of the pathogen by the host's innate immune system and countermeasures taken by the pathogen. Detection of invading bacteria by the host leads to rapid activation of the transcription factor NF-kappaB, followed by inflammation and eradication of the intruders. In response, some pathogens, including enteropathogenic Escherichia coli (EPEC), acquired means of blocking NF-kappaB activation. We show that inhibition of NF-kappaB activation by EPEC involves the injection of NleE into the host cell. Importantly, we show that NleE inhibits NF-kappaB activation by preventing activation of IKKbeta and consequently the degradation of the NF-kappaB inhibitor, IkappaB. This NleE activity is enhanced by, but is not dependent on, a second injected effector, NleB. In conclusion, this study describes two effectors, NleB and NleE, with no similarity to other known proteins, used by pathogens to manipulate NF-kappaB signaling pathways.

DOI: 10.1371/journal.ppat.1000743

8 Figures and Tables

Citations per Year

147 Citations

Semantic Scholar estimates that this publication has 147 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Nadler2010TheTI, title={The type III secretion effector NleE inhibits NF-kappaB activation.}, author={Chen Nadler and Kobi Baruch and Simi Kobi and Erez Mills and Gili Haviv and Marganit Farago and Irit Alkalay and Sina Bartfeld and Thomas F Meyer and Yinon Ben-Neriah and Ilan Rosenshine}, journal={PLoS pathogens}, year={2010}, volume={6 1}, pages={e1000743} }